CompletedNCT00314314
Insulin and cognitive performance in people with bipolarity
About this title
The Effect of Intranasal Insulin on Neurocognitive Function in Euthymic Patients With Bipolar Disorder
Read the official source — NCT00314314Medication studyAges 18–60Canada
Understand this study
Who was this study for?
This study was for people with bipolarity. Listed age limits: 18 years to 60 years. Other eligibility criteria applied.
- Listed locations
- TorontoSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Study information
Study start dateMay 2006
- Recruitment status
- Completed
- Enrollment listed in the registry
- 60
- Sponsor
- University Health Network, Toronto
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- Canada
- Age range
- From 18 Years to 60 Years
- Official registry ID
- NCT00314314
- Official title
Show the full official title
A Randomized, Double-Blind Controlled Trial Evaluating the Effect of Intranasal Insulin on Neurocognitive Function in Euthymic Patients With Bipolar Disorder
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Toronto
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University Health Network, Toronto, a university.
Did this study involve medication?
Yes. The study involved medication, including Intranasal Insulin and Diluent.
Who was this study for?
This study was for people with bipolarity. Listed age limits: 18 years to 60 years. Other eligibility criteria applied.
